This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vail Scientific, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Thomas W Burke
Introduction
Thomas W Burke is an accomplished inventor based in Plymouth, MN (US). He has made significant contributions to the field of medical diagnostics, particularly in the assessment of sepsis risk. His innovative approach utilizes nitric oxide concentrations in exhaled breath to determine a patient's risk of developing sepsis.
Latest Patents
Thomas W Burke holds a patent for an "Apparatus and method for the determination of endothelial dysfunction and sepsis risk using nitric oxide concentrations in exhaled breath." This method involves collecting an exhaled breath sample and determining the nitric oxide concentration within it. The sepsis risk score is then correlated to this concentration, providing valuable insights into a patient's health status. The method may also incorporate additional measurements of vital statistics, such as end-tidal CO, respiratory rate, and body temperature, to enhance the accuracy of the sepsis risk score.
Career Highlights
Burke's career is marked by his dedication to advancing medical technology. He is currently associated with Vail Scientific, Inc., where he continues to innovate and develop solutions that address critical health challenges. His work has the potential to improve patient outcomes significantly.
Collaborations
Throughout his career, Thomas W Burke has collaborated with notable colleagues, including Russell L Morris and Carter R Anderson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Thomas W Burke's contributions to medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare. His work in determining sepsis risk using nitric oxide concentrations is a testament to the impact of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile